Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Activated Protein C Resistance

raloxifene hydrochloride has been researched along with Activated Protein C Resistance in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahm, AEA; Eilertsen, AL; Høibraaten, E; Lofthus, CM; Mowinckel, MC; Sandset, PM1
Duschek, EJ; Neele, SJ; Netelenbos, C; Rosing, J; Thomassen, MC1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM1

Trials

3 trial(s) available for raloxifene hydrochloride and Activated Protein C Resistance

ArticleYear
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1

    Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis

2019
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:8

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Homocysteine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride

2004
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis

2007